Duvillard P - Search Results

1

Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.

Rebischung C, Pautier P, Morice P, Lhomme C, Duvillard P. Rebischung C, et al. Among authors: duvillard p. Gynecol Oncol. 2000 Apr;77(1):203-5. doi: 10.1006/gyno.1999.5653. Gynecol Oncol. 2000. PMID: 10739713

2

Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.

Dubernard G, Morice P, Rey A, Camatte S, Pautier P, Lhommé C, Duvillard P, Castaigne D. Dubernard G, et al. Among authors: duvillard p. Gynecol Oncol. 2005 Apr;97(1):136-41. doi: 10.1016/j.ygyno.2004.12.002. Gynecol Oncol. 2005. PMID: 15790449

3

Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.

Leary A, Petrella MC, Pautier P, Duvillard P, Uzan C, Tazi Y, Ledoux F, Gouy S, Morice P, Lhommé C. Leary A, et al. Among authors: duvillard p. Gynecol Oncol. 2014 Jan;132(1):23-7. doi: 10.1016/j.ygyno.2013.11.006. Epub 2013 Nov 9. Gynecol Oncol. 2014. PMID: 24219980

4

Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.

Michels J, Genestie C, Dunant A, Caron O, Lanoy E, Colomba E, Pommeret F, Rey A, Gouy S, Duvillard P, Teuff GL, Larue C, Savoye AM, Lhommé C, Leary A, Morice P, Pautier P. Michels J, et al. Among authors: duvillard p. Gynecol Oncol. 2021 Jan;160(1):77-82. doi: 10.1016/j.ygyno.2020.09.050. Epub 2020 Oct 12. Gynecol Oncol. 2021. PMID: 33059915

5

A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.

Culine S, Kattan J, Lhomme C, Duvillard P, Michel G, Castaigne D, Leclere J, Pico J, Droz JP. Culine S, et al. Among authors: duvillard p. Gynecol Oncol. 1994 Jul;54(1):47-53. doi: 10.1006/gyno.1994.1164. Gynecol Oncol. 1994. PMID: 7517380 Clinical Trial.

6

Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.

Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Gerbaulet A, Droz JP. Culine S, et al. Among authors: duvillard p. Gynecol Oncol. 1995 Sep;58(3):344-8. doi: 10.1006/gyno.1995.1240. Gynecol Oncol. 1995. PMID: 7672699

7

Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.

Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP. Culine S, et al. Among authors: duvillard p. J Surg Oncol. 1996 May;62(1):40-5. doi: 10.1002/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R. J Surg Oncol. 1996. PMID: 8618400

8

Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience.

Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz JP. Culine S, et al. Among authors: duvillard p. Gynecol Oncol. 1997 Jan;64(1):160-5. doi: 10.1006/gyno.1996.4547. Gynecol Oncol. 1997. PMID: 8995567

9

Primary yolk sac tumor of the endometrium: a case report and review of the literature.

Spatz A, Bouron D, Pautier P, Castaigne D, Duvillard P. Spatz A, et al. Among authors: duvillard p. Gynecol Oncol. 1998 Aug;70(2):285-8. doi: 10.1006/gyno.1998.5036. Gynecol Oncol. 1998. PMID: 9740707 Review.

10

Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma.

Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, Duvillard P. Morice P, et al. Among authors: duvillard p. Gynecol Oncol. 1999 Apr;73(1):106-10. doi: 10.1006/gyno.1998.5308. Gynecol Oncol. 1999. PMID: 10094889 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters